On Wednesday, Shares of VMware, Inc. (NYSE:VMW), gained 6.52% to $90.97.
VMware, declared financial results for the first quarter of 2015:
- Total revenues for the first quarter were $1.51 billion, an raise of 11% from the first quarter of 2014, or up 13% year-over-year in constant currency.
- License revenues for the first quarter were $576 million, an raise of 3% from the first quarter of 2014, or up 6% year-over-year in constant currency.
- GAAP operating income for the first quarter was $218 million, a decrease of 9% from the first quarter of 2014. Non-GAAP operating income for the first quarter was $451 million, an raise of 7% from the first quarter of 2014. Both GAAP and Non-GAAP results on a year-over-year basis comprise the influence of the acquisition of AirWatch, accomplished in the first quarter of 2014.
- GAAP net income for the first quarter was $196 million, or $0.45 per diluted share, down 1% per diluted share contrast to $199 million, or $0.46 per diluted share, for the first quarter of 2014. Non-GAAP net income for the quarter was $369 million, or $0.86 per diluted share, up 7% per diluted share contrast to $348 million, or $0.80 per diluted share, for the first quarter of 2014. Both GAAP and Non-GAAP results on a year-over-year basis comprise the influence of the acquisition of AirWatch, accomplished in the first quarter of 2014.
- Operating cash flows for the first quarter were $683 million. Free cash flows for the quarter were $577 million.
- Cash, cash equivalents and short-term investments were $7.23 billion, and unearned revenues were $4.74 billion as of March 31, 2015.
- Total revenues plus sequential change in total unearned revenues declined 1% year-over-year, grew 4% year-over-year when adjusted for constant currency, and grew 7% year-over-year when adjusted for constant currency and attained unearned revenues from the AirWatch acquisition in Q1 2014.
- License revenues plus sequential change in unearned license revenues was flat year-over-year, grew 5% year-over-year when adjusted for constant currency, and grew 9% year-over-year when adjusted for constant currency and attained unearned license revenues from the AirWatch acquisition in Q1 2014.
VMware, Inc. provides virtualization infrastructure solutions in the United States and internationally. The company’s virtualization infrastructure solutions comprise a suite of products designed to deliver a software-defined data center (SDDC), run on industry-standard desktop computers and servers, and support a range of operating system and application environments, in addition to networking and storage infrastructures.
Shares of St. Jude Medical Inc. (NYSE:STJ), gained 6.41% to $73.55, during its last trading session.
St. Jude Medical, stated sales and net earnings for the first quarter ended April 4, 2015.
First Quarter 2015 Sales
The company stated net sales of $1.345 billion in the first quarter of 2015, a 1 percent decrease contrast to net sales of $1.363 billion in the first quarter of 2014. On a constant currency basis, net sales raised by about 5 percent contrast to the first quarter of 2014.
Commenting on the company’s financial results, St. Jude Medical Chairman, President and Chief Executive Officer Daniel J. Starks said, “St. Jude Medical’s first quarter revenue exceeded formerly declared guidance, driven by our growth in atrial fibrillation, neuromodulation and our CardioMEMS technology platform. These results reinforce our confidence that St. Jude Medical is on track to accelerate constant currency sales growth in 2015.”
St. Jude Medical, Inc., together with its auxiliaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm administration, cardiovascular, and atrial fibrillation therapy areas worldwide.
At the end of Wednesday’s trade, Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), gained 6.25% to $2.04, hitting its highest level.
AVEO Pharmaceuticals, declared the appointment of Keith S. Ehrlich to the position of chief financial officer. In this role, Mr. Ehrlich will be responsible for the company’s financial and administrative strategy and administration, and will serve on the executive leadership team which governs corporate strategy. He will report to Michael Bailey, AVEO’s president and chief executive officer.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for patients with cancer and related diseases. Its product candidates under development comprise Tivozanib, an tyrosine kinase inhibitor for various vascular endothelial growth factors; Ficlatuzumab, a hepatocyte growth factor inhibitory antibody, which has accomplished Phase II trial; and AV-203, an anti-ErbB3 monoclonal antibody that has accomplished a Phase I dose escalation study.
Finally, Angie’s List, Inc. (NASDAQ:ANGI), ended its last trade with 5.04% gain, and closed at $6.46.
Angie’s List, declared financial results for the quarter ended March 31, 2015.
First Quarter Results
Total revenue for the first quarter of 2015 was $83.5 million, an raise of 15 percent contrast to the preceding year period. Membership revenue in the first quarter of 2015 was $17.3 million, a decrease of 5 percent contrast to the preceding year period. Service provider revenue remains the largest and fastest growing component of total revenue at $66.2 million for the quarter, representing a 22 percent growth rate year over year. Service provider revenue comprises revenue from advertising contracts and fees from e-commerce transactions.
Marketing expense reduced 31 percent, or $7.2 million, contrast to the year-ago period. Net income for the first quarter was $4.4 million, with selling expense of $28.6 million and marketing expense of $16.3 million, contrast to a net loss of $3.8 million, with selling expense of $26.1 million and marketing expense of $23.5 million, in the year-ago period. Adjusted EBITDA, a non-GAAP financial measure, was $8.6 million for the period as contrast to a loss of $0.6 million in the year-ago period.
Cash offered by operations for the first quarter was about $21.2 million. At March 31, 2015, the balance of cash, cash equivalents and investments was $77.5 million.
Angie’s List, Inc. operates a local services marketplace and consumer review site in the United States. The company provides marketplace to research, shop for, and purchase local services for home, health, and automotive service needs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
